XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
STOCKHOLDERS' EQUITY (DEFICIT) (Tables)
 9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan The following table presents the Company's total share based compensation expense by award type for the three and nine months ended September 30, 2023 and 2022:
(In thousands)Three Months Ended
September 30,		Nine Months Ended
September 30,
2023202220232022
RSUs$5,112 $6,219 $16,750 $14,471 
Performance RSUs2,288 2,044 6,520 3,544 
Options791 2,174 4,285 6,567 
Total Share Based Compensation Expense$8,191 $10,437 $27,555 $24,582 
Schedule of Computation of Income (Loss) per Share
(In thousands, except per share data)Three Months Ended
September 30,		Nine Months Ended
September 30,
 2023202220232022
NUMERATOR:    
Net loss attributable to the Company – common shares$(9,053)$(310,363)$(1,115,783)$(344,544)
DENOMINATOR(1):
   
Weighted average common shares outstanding - basic149,695 148,299 149,084 147,957 
  Stock options and restricted stock(2):
— — — — 
Weighted average common shares outstanding - diluted149,695 148,299 149,084 147,957 
Net loss attributable to the Company per common share:   
Basic$(0.06)$(2.09)$(7.48)$(2.33)
Diluted$(0.06)$(2.09)$(7.48)$(2.33)
(1) All of the outstanding Special Warrants are included in both the basic and diluted weighted average common shares outstanding of the Company for the three and nine months ended September 30, 2023 and 2022.
(2) Outstanding equity service awards representing 14.6 million and 11.7 million shares of Class A common stock of the Company for the three months ended September 30, 2023 and 2022, respectively, and 13.3 million and 10.8 million for the nine months ended September 30, 2023 and 2022 respectively, were not included in the computation of diluted earnings per share because to do so would have been antidilutive.